Xplico news

  • Skærmbillede 2018-08-24 kl. 16.04.22

Xplico article for Biotech & Money / LSX

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, […]

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team

Xplico is pleased to announce that Sisse Ramsing Escargueil has joined our team as Executive Assistant and will be working […]

  • 1

Xplico Interview with Biotech & Money / LSX

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, […]

  • Xplico_Gazelle

Xplico named “a 2017 Gazelle Company” (a growth company) for the second year in a row by the leading Danish business newspaper Boersen.

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2017 Gazelle Company for the 2nd […]

Xplico launches Xplico Captable – a cap table providing simulations and waterfall analysis of the various stakeholders’ investments and values in a company.

Xplico Captable is a capitalization table providing simulations and waterfall analysis of the founders’ and investors’ percentage of ownership, equity […]

Xplico is pleased to announce that Golnaz Borghei has joined our valuation team.

Golnaz has 10+ years’ experience in biotech and medtech research and industry. She holds a PhD in Analytical Biotechnology from […]

  • Xplico_Gazelle_2016

Xplico named “a 2016 Gazelle Company” (a growth company) by the leading Danish business newspaper Boersen.

We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2016 Gazelle Company. Børsen analyses every […]

Xplico is pleased to announce that Peter Abelin has joined our valuation team.

Xplico is pleased to announce that Peter Abelin has joined our valuation team.
Peter has more than 25 years’ experience […]